Ryman Healthcare - Consolidated Financial Statements FY25
Ryman Healthcare Limited
Provider claim
Community provider
2026-10-10
Next review: 2027-04-10
New Zealand and Australia
High confidence
verified
Primary-source FY25 operator-report audit, 10 October 2026
Evidence boundary: Historical Ryman consolidated financial statements for the year ended 31 March 2025, not the full annual report. All preserved pages were text-inspected, selected dates/table/audit pages visually checked, and the current issuer PDF was byte-matched on 10 October 2026. High confidence concerns source identity and specific financial cells, not an investment recommendation or independent care-quality assessment. PwC’s financial audit gives reasonable assurance within its stated scope; other annual-report information is outside the audit opinion. NZ$000 group values include New Zealand and Australia, resident deposits/occupation rights, valuation changes and financing/tax effects. PBTF is non-GAAP; cash-flow and debt definitions must not be substituted for one another. Prior periods are restated. Commitments and valuation assumptions are not completed projects or present staffing, vacancies or occupancy. Board authorisation 28 May 2025, public results/audit date 29 May 2025, June 2026 access and 10 October 2026 review are separate. Newer issuer reporting exists; this preserved FY25 edition is not labelled current FY26 evidence. Original filename, bytes, hash and category are retained.
Short Answer
Standalone FY25 Ryman consolidated accounts and financial audit, with restated comparatives, New Zealand/Australia segments and valuation/financing notes; financial evidence, not a full annual-report narrative or clinical evaluation.
Why it matters
Use the accounts to distinguish revenue, valuation movements, impairments, resident liabilities, operating cash flows and borrowings, and to understand restated comparative periods. Check each note’s group/segment geography and measurement basis before comparing operators; use other current sources for service, admissions or care-quality decisions.
Key Points
- •The accounts cover the year ended 31 March 2025 and were authorised for issue on 28 May 2025 (physical p.6, printed p.5). The issuer’s FY25 results release and PwC audit are dated 29 May 2025; PDF production, financial year and June 2026 access are separate dates.
- •The preserved standalone PDF has 93 physical pages: cover, financial statements/notes and PwC audit (physical pp.90–93, printed pp.89–92). The current issuer PDF was byte-identical on 10 October 2026.
- •Consolidated FY25 total revenue was NZ$760.695 million; FY24 comparative revenue is NZ$689.886 million as restated (physical p.2, printed p.1; NZ$000 table). These are group figures spanning New Zealand and Australia, not New Zealand care-only revenue.
- •FY25 group net loss after tax was NZ$436.831 million, compared with a restated FY24 loss of NZ$169.665 million (physical p.2, printed p.1). The statement includes impairments, fair-value movements, financing costs and tax; this is not a cash-loss or facility-quality measure.
- •Profit/(loss) before income tax and fair-value movements (PBTF) is expressly a non-GAAP measure without a standardised GAAP meaning; the statement warns it may not be comparable with other entities’ measures (physical p.2, printed p.1).
- •At 31 March 2025, consolidated total assets were NZ$12,063.362 million and interest-bearing loans/borrowings NZ$1,682.552 million (physical p.6, printed p.5). Gross borrowings are not the same measure as net interest-bearing debt.
Full Summary & Notes
Ryman Healthcare Limited’s consolidated financial statements for the year ended 31 March 2025 cover its New Zealand and Australian group. This 93-page source is the standalone accounts and PwC auditor’s report, not the full annual report or a care-service directory. Published with the 29 May 2025 results, it reports total revenue of NZ$760.695 million and a group net loss after tax of NZ$436.831 million. Extensive accounting changes and corrections restate earlier comparisons. The statements explain property valuations, resident deposits and occupation advances, borrowings, cash flows, tax and commitments; they do not measure current national care capacity or a resident’s service entitlement.
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
Historical FY25 Radius company report: portfolio activity, diversification, development plans, governance and audited group accounts; not a national capacity, staffing or clinical-quality assessment.
Summerset FY2025 company report released February 2026: retirement/care portfolio, delivered occupation-right units, development pipeline, financial results, governance and sustainability; future plans and corporate service claims remain qualified.
Historical FY2024 operator report on care occupancy, resident and employee feedback, development, audited financial statements, climate scenarios and governance; underlying profit and care-quality narrative have separate assurance limits.
FY2024 care operator report on high-acuity beds, employee and resident feedback, RConnect staffing, community activity, new home-support plans and audited financial results; 49 PDF spreads contain the numbered report through page 95.
Historical FY2025 report covering village and co-located care capacity, mixed unit/suite completions, workforce feedback, development plans, emissions accounting and audited financial statements; portfolio excludes the Palmerston North joint venture.
42-page FY2026 financial annual report with a short portfolio and leadership overview, audited statements, valuation and resident-loan notes, planned development and limited resident-feedback reporting; separate from the two-page results release.